Dose increases can trigger temporary recurrence of tiredness, even in patients who had previously adapted well
Gervais, M., Labouebe, G., Picard, A., Thorens, B
A phase III trial (NCT01909453) compares the effectiveness and safety of LGX818 with MEK162 to vemurafenib and LGX818 monotherapy in patients with locally progressed, unresectable, or metastatic melanoma with the BRAF V600 mutation in two parts
The unwanted comments about body changes are particularly insidous because they create this weird situation where you're managing other people's feelings about your body while processing your own relationship shifts
Superscript III (Thermo Fisher) and RNase out and dNTPs were added, before samples were placed into a thermocycler for 5 min at 25 C, 60 min at 50 C and 15 min at 70 C